Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
RegVelo, a new AI technology, allows researchers to predict not only how cells acquire their identities, but what path they ...
Completed phase 1a dose escalation study of the first oral ENPP1 inhibitor RBS2418 immunotherapy in subjects with metastatic solid tumors. SECN-15: A novel treatment option for patients with ...
Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow. There is currently no cure. However, various therapies can stabilize ...
GC Therapeutics (GCTx), a pioneering biotechnology company advancing the next generation of cell-based medicines through its ...
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
CD19-CAR T-cell treatment is a novel option of deep B cell depletion with promising results across different rheumatologic and musculoskeletal diseases (RMD). This and other cell-depleting approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results